Accu-Chek FastClix
Our consumer lancing device is designed for comfort and ease-of-use that’s virtually pain free1.
Benefits
- Simple Your patients can prime and release in 1-Click action
- Gentle Clixmotion technology enables guided lancet motion, and 11 depth settings to suit individual skin types
- Unique 6 lancets contained in a drum - there are no single lancets to see or touch
- Convenient Used lancet drums can be disposed of in household waste‡ (unless other regulations apply locally)‡
Connect with a representative
Do you have questions, or are you ready to see a demo? Schedule a call, and we'll show you what we can do for you, your team, and your patients.
Request demoNeed help with your patients' products?
From how-to-videos and FAQs to product manuals, our support resources are here for you and your patients every step of the way.
Product Support
Disclaimers:
Safety advice: The Accu-Chek FastClix finger pricker is intended for patient self-monitoring by an individual person only. It must not be used to collect blood in a multipatient setting as it does not incorporate any features to guard against cross infection.
‡ Some local councils provide a sharps disposal service. Check with the local council which disposal services are available. Many NHS organisations have sharps policies outlining their requirements for provisions in patients’ homes. For example, for patients who are carriers of infectious diseases, recommendations usually suggest that suitable arrangements need to be made for the disposal of the used articles as contaminated waste.
The mySugr logbook is licensed for people with diabetes over the age of 16 years. The mySugr Bolus Calculator is licensed for people with diabetes over the age of 18 years. Users will need to be at least 18 years old to register.
References:
1. Jendrike N et al. Pain sensation at Fingertips and Palm by using different Blood Glucose Monitoring Systems. Diabetes Technology Meeting. San Francisco, 5-7 November 2009.
BGM easier (Accu-Chek Instant Target Range Indicator): Parkin CG, et al. Use of an Integrated Tool for Interpretation of Blood Glucose Data Improves Correctness of Glycemic Risk Assessment in Individuals with Type 1 and Type 2 Diabetes. J Diabetes Sci Technol. 2016 Sep 12.
UK version of mySugr real world evidence: Ide C, et al. Real World Data analysis shows a significant improvement in glycaemic management when using a blood glucose monitor connected with a mobile health application in UK users with Type 2 Diabetes. Diabetes UK Professional Conference Poster Session, Liverpool, 26‑28 Apr 2023, Poster 198